Drug Discovery Innovation Programme (DDIP)

𝐀𝐭𝐭𝐞𝐧𝐝𝐞𝐞 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐬📊 𝐀 𝐓𝐫𝐮𝐥𝐲 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐄𝐯𝐞𝐧𝐭, 𝐰𝐢𝐭𝐡 𝐀𝐭𝐭𝐞𝐧𝐝𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐀𝐭𝐭𝐞𝐧𝐝𝐞𝐞𝐬 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: ➡ Europe: 83% ➡ USA: 10% ➡ Japan and Rest of the World: 7% 𝐀𝐭𝐭𝐞𝐧𝐝𝐞𝐞𝐬 𝐛𝐲 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: ➡ Pharma & Biotech: 80% ➡ Academics: 10% ➡ Service Providers: 10% Join us as various Industry-leading companies and institutions will be represented at the 24𝐭𝐡 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞. 📅 𝐃𝐚𝐭𝐞: 17-18 September, 2024 🗺 𝐋𝐨𝐜𝐚𝐭𝐢𝐨𝐧: Barcelona, Spain 𝐁𝐨𝐨𝐤 𝐲𝐨𝐮𝐫 𝐬𝐥𝐨𝐭 𝐧𝐨𝐰: https://shorturl.at/kwyFZ 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐞𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬: https://bit.ly/4ac9Shb 𝐄𝐦𝐚𝐢𝐥 𝐮𝐬 𝐚𝐭: info@worldbigroup.com #drugdiscovery #leadership #drugdiscovery #innovation #genomics #sciencestudent #steam #scientist #biologics #demographics #medicinalchem #drugdiscovery #oncology #bioinformatics #genomics #medicinalchemistry #molecularbiology #antibodyengineering #toxicology #structuralbiology #licensing #drugdiscoveryconference #ddip #ddipeu #worldbievents #scienceresearch #ddip24 AbbVie | Abtech Therapeutics | Adalvo | Ahead Therapeutics | Almirall | Amgen | Astex Pharmaceuticals | AstraZeneca | BSIM Therapeutics | Bayer | Brigham and Women's Hospital | Boehringer Ingelheim | Bristol Myers Squibb | CHARM Therapeutics | Chugai Pharma Europe | Dana-Farber Cancer Institute | DanausGT | Dracen Pharmaceuticals, Inc. | ESSA Pharma | Genentech | Gilead Sciences | GSK | Janssen Inc. | Johnson & Johnson | St. Jude Children's Research Hospital | Eli Lilly and Company | Merck | Mitsubishi Tanabe Pharma America | National Cancer Centre Singapore | National Center for Advancing Translational Sciences (NCATS) | Nissan Chemical America Corporation | Novartis | Nurix Therapeutics | Pfizer | Regeneron | Roche | Yuhan Corporation | Taisho Pharmaceutical Holding Co Ltd | Vertex Pharmaceuticals

𝓔𝓂𝓅𝓸𝓌𝓮𝓇𝒾𝓃𝓰 𝒯𝓸𝓂𝓸𝓇𝓇𝓸𝓌'𝓈 , 𝓑𝓇𝓮𝒶𝓀𝓉����𝓇𝓸𝓊𝓰𝒽𝓈 𝒾𝓃 𝓜𝓮𝒹𝒾𝒸𝒾𝓃𝓮 𝒯𝓸𝒹𝒶𝓎 𝑻𝒉𝒆 𝑭𝒖𝒕𝒖𝒓𝒆 𝒐𝒇 𝑫𝒓𝒖𝒈 𝑫𝒊𝒔𝒄𝒐𝒗𝒆𝒓𝒚 Embracing Biotech Startups and Technological Advancements. With conferences like the Drug Discovery Innovation Programme by World BI, support initiatives, enhanced collaborations, AI integration, and evolving regulatory frameworks. 𝑭𝒐𝒍𝒍𝒐𝒘 𝒖𝒔 𝒇𝒐𝒓 𝒎𝒐𝒓𝒆 𝒖𝒑𝒅𝒂𝒕𝒆𝒔 𝒐𝒏 𝒈𝒓𝒐𝒖𝒏𝒅𝒃𝒓𝒆𝒂𝒌𝒊𝒏𝒈 𝒂𝒅𝒗𝒂𝒏𝒄𝒆𝒎𝒆𝒏𝒕𝒔 #drugdiscovery #biotechstartups #medicalinnovation #personalizedmedicine #techadvancements #aiinhealthcare #collaboration #partnerships #regulatoryevolution #worldbi #drugdiscoveryinnovation #futureofmedicine

𝑺𝒑𝒐𝒏𝒔𝒐𝒓 𝑨𝒏𝒏𝒐𝒖𝒏𝒄𝒆𝒎𝒆𝒏𝒕 𝑷𝒓𝒆𝒔𝒆𝒏𝒕𝒂𝒕𝒊𝒐𝒏 𝑷𝒂𝒓𝒕𝒏𝒆𝒓 Selvita 𝘎𝘳𝘰𝘶𝘱 𝘩𝘢𝘴 𝘣𝘳𝘰𝘢𝘥 𝘦𝘹𝘱𝘦𝘳𝘵𝘪𝘴𝘦 𝘢𝘯𝘥 𝘵𝘳𝘢𝘤𝘬 𝘳𝘦𝘤𝘰𝘳𝘥 𝘪𝘯 𝘰𝘯𝘤𝘰𝘭𝘰𝘨𝘺, 𝘪𝘯𝘧𝘭𝘢𝘮𝘮𝘢𝘵𝘪𝘰𝘯, 𝘧𝘪𝘣𝘳𝘰𝘴𝘪𝘴, 𝘢𝘯𝘵𝘪-𝘪𝘯𝘧𝘦𝘤��𝘪𝘷𝘦𝘴, 𝘳𝘦𝘴𝘱𝘪𝘳𝘢𝘵𝘰𝘳𝘺 𝘥𝘪𝘴𝘦𝘢𝘴𝘦𝘴 𝘢𝘯𝘥 𝘊𝘕𝘚. 𝘛𝘩𝘦 𝘤𝘰𝘮𝘱𝘢𝘯𝘺 𝘰𝘧𝘧𝘦𝘳𝘴 𝘥𝘳𝘶𝘨 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘢𝘵 𝘦𝘷𝘦𝘳𝘺 𝘴𝘵𝘢𝘨𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘦𝘢𝘳𝘭𝘺 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘱𝘩𝘢𝘴𝘦 𝘶𝘱 𝘵𝘰 𝘵𝘩𝘦 𝘱𝘳𝘦𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵. 𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝒐𝒖𝒓 𝒘𝒆𝒃𝒔𝒊𝒕𝒆: https://bit.ly/3xEKWRT #drugdiscovery #leadership #drugdiscovery #innovation #genomics #toxicology #structuralbiology #licensing #drugdiscoveryconference #ddipeu #worldbievents #scienceresearch

𝑺𝒑𝒐𝒏𝒔𝒐𝒓 𝑨𝒏𝒏𝒐𝒖𝒏𝒄𝒆𝒎𝒆𝒏𝒕 𝘕𝘦𝘵𝘸𝘰𝘳𝘬𝘪𝘯𝘨 𝘗𝘢𝘳𝘵𝘯𝘦𝘳 𝘐𝘯𝘰𝘷𝘪𝘦𝘮 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘧𝘪𝘤 𝘪𝘴 𝘢 𝘣𝘪𝘰𝘢𝘯𝘢𝘭𝘺𝘵𝘪𝘤𝘢𝘭 𝘗𝘳𝘪𝘷𝘢𝘵𝘦 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘖𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯 (𝘦𝘴𝘵𝘢𝘣𝘭𝘪𝘴𝘩𝘦𝘥 𝘪𝘯 2011 𝘪𝘯 𝘚𝘵𝘳𝘢𝘴𝘣𝘰𝘶𝘳𝘨). 𝘞𝘦 𝘥𝘦𝘭𝘪𝘷𝘦𝘳 𝘦𝘯𝘢𝘣𝘭𝘪𝘯𝘨 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘴𝘦𝘤𝘶𝘳𝘦 𝘥𝘳𝘶𝘨 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘱𝘳𝘰𝘨𝘳𝘢𝘮𝘴 𝘢𝘯𝘥 𝘵𝘰 𝘵𝘢𝘬𝘦 𝘪𝘯𝘧𝘰𝘳𝘮𝘦𝘥 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘣𝘺 𝘤𝘭𝘰𝘴𝘪𝘯𝘨 𝘵𝘩𝘦 𝘨𝘢𝘱 𝘣𝘦𝘵𝘸𝘦𝘦𝘯 𝘱𝘳𝘦𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵. 𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝒐𝒖𝒓 𝒘𝒆𝒃𝒔𝒊𝒕𝒆: https://bit.ly/3xEKWRT #drugdiscovery #leadership #drugdiscovery #innovation #genomics #toxicology #structuralbiology #licensing #drugdiscoveryconference #ddipeu #worldbievents #scienceresearch | Inoviem Scientific

“There is growing consensus in favor of returning individual specific research results that are clinically #actionable, valid, and reliable. However, deciding what and how research results should be returned [to study participants and their treating physicians] remains a considerable challenge.”   A few weeks ago, researchers from Stanford University School of Medicine and Department of Health Sciences and Technology (D-HEST), ETH Zürich uploaded the manuscript “Researcher Views on Multi-omics Return of Results to Research Participants: Insights from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) Study” on a preprint server[1].   Our COO, Rudi Schmidt, will include this aspect in his presentation at the 24th Drug Discovery Innovation Programme (DDIP) in Barcelona when talking about "Evaluating #actionability of current and future insights from #multiomics, #PrecisionMedicine and #AI.”   Another part of his analysis will be the publication “Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?”[2]   His presentation will focus on how to overcome the challenges in drug development and translational discordance with multi-omics and AI approaches. How can multi-omics and AI adress issues such as poor hypotheses, irreproducible data, ambiguous preclinical models, statistical errors, clinical relevance of basic research and data sharing? The presentation will summarize the latest strategies to evaluate and overcome these problems during the drug discovery and development process. References - check 1st comment Event: https://lnkd.in/e_-J9uWp Ayesha F.

𝐖𝐡𝐨 𝐖𝐢𝐥𝐥 𝐀𝐭𝐭𝐞𝐧𝐝 𝐭𝐡𝐞 24𝐭𝐡 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞? Join us and meet prestigious assembly of industry leaders, including Chief Scientific Officers, CEOs, VPs of R&D, Directors of Drug Discovery, Senior Scientists, and many more. 𝓖𝓮𝓽 𝓽𝓱𝓮 𝓕𝓾𝓵𝓵 𝓐𝓽𝓽𝓮𝓷𝓭𝓮𝓮 𝓛𝓲𝓼𝓽! https://shorturl.at/kwyFZ #drugdiscovery #drugdiscovery #innovation #genomics #toxicology #structuralbiology #licensing #drugdiscoveryconference #ddip #ddipeu #worldbievent #scienceresearch #ddip24

𝑺𝒑𝒆𝒂𝒌𝒆𝒓 𝑨𝒏𝒏𝒐𝒖𝒏𝒄𝒆𝒎𝒆𝒏𝒕 Meet our eminent guest speaker, Shayoni Dutta, Data Science Manager of GSK, at the 24th Drug Discovery Innovation Programme. 𝑹𝒆𝒔𝒆𝒓𝒗𝒆 𝒚𝒐𝒖𝒓 𝒔𝒑𝒐𝒕 𝒏𝒐𝒘: https://shorturl.at/kwyFZ 𝑭𝒐𝒓 𝑨𝒅𝒅𝒊𝒕𝒊𝒐𝒏𝒂𝒍 𝑸𝒖𝒆𝒓𝒊𝒆𝒔: https://bit.ly/4ac9Shb 𝑪𝒐𝒏𝒕𝒂𝒄𝒕 𝒖𝒔 𝒗𝒊𝒂 𝒆𝒎𝒂𝒊𝒍: info@worldbigroup.com #drugdiscovery #drugdiscovery #innovation #genomics #toxicology #structuralbiology #licensing #drugdiscoveryconference #ddip #ddipeu #worldbievent #scienceresearch #ddip24

𝑬𝒙𝒉𝒊𝒃𝒊𝒕𝒊𝒐𝒏 𝑷𝒂𝒓𝒕𝒏𝒆𝒓 𝘑𝘰𝘪𝘯 𝘶𝘴 𝘢𝘯𝘥 𝘮𝘦𝘦𝘵 Ali Hoseini, PhD, MBA, PhD, MBA, 𝘋𝘪𝘳𝘦𝘤𝘵𝘰𝘳 𝘰𝘧 IRBM, 𝘌𝘜 𝘉𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵, 𝘢𝘵 𝘵𝘩𝘦 24𝘵𝘩 𝘋𝘳𝘶𝘨 𝘋𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘗𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘦. 𝑹𝒆𝒔𝒆𝒓𝒗𝒆 𝒚𝒐𝒖𝒓 𝒔𝒑𝒐𝒕 𝒏𝒐𝒘: https://shorturl.at/kwyFZ #drugdiscovery #drugdiscovery #innovation #genomics #toxicology #structuralbiology #sponsor #drugdiscoveryconference #ddipeu #worldbievent #scienceresearch #ddip24

𝑫𝒊𝒅 𝒀𝒐𝒖 𝑲𝒏𝒐𝒘! 𝘈𝘐 𝘪𝘴 𝘳𝘦𝘷𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘪𝘻𝘪𝘯𝘨 𝘥𝘳𝘶𝘨 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺, 𝘢𝘤𝘤𝘦𝘭𝘦𝘳𝘢𝘵𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯, 𝘢𝘯𝘥 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘪𝘯𝘨 𝘵𝘳𝘢𝘥𝘪𝘵𝘪𝘰𝘯𝘢𝘭 𝘮𝘦𝘵𝘩𝘰𝘥𝘴 𝘣𝘺 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘪𝘯𝘨 𝘮𝘢𝘴𝘴𝘪𝘷𝘦 𝘨𝘦𝘯𝘦𝘵𝘪𝘤 𝘢𝘯𝘥 𝘤𝘩𝘦𝘮𝘪𝘤𝘢𝘭 𝘥𝘢𝘵𝘢𝘣𝘢𝘴𝘦𝘴. #drugdiscovery #leadership #drugdiscovery #innovation #genomics #sciencestudent #steam #scientist #biologics #medicinalchem #drugdiscovery #oncology #drugdiscoveryconference #worldbievents #scienceresearch

𝑺𝒑𝒐𝒏𝒔𝒐𝒓 𝑨𝒏𝒏𝒐𝒖𝒏𝒄𝒆𝒎𝒆𝒏𝒕 𝑵𝒆𝒕𝒘𝒐𝒓𝒌𝒊𝒏𝒈 𝑷𝒂𝒓𝒕𝒏𝒆𝒓 𝘖𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘢𝘵 Causaly 𝘪𝘴 𝘵𝘰 𝘳𝘦𝘥𝘦𝘧𝘪𝘯𝘦 𝘵𝘩𝘦 𝘣𝘰𝘶𝘯𝘥𝘢𝘳𝘪𝘦𝘴 𝘰𝘧 𝘩𝘶𝘮𝘢𝘯 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘣𝘺 𝘩𝘢𝘳𝘯𝘦𝘴𝘴𝘪𝘯𝘨 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘷𝘦 𝘈𝘐 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘦𝘴. 𝘍𝘰𝘶𝘯𝘥𝘦𝘥 𝘪𝘯 2018, 𝘊𝘢𝘶𝘴𝘢𝘭𝘺’𝘴 𝘶𝘯𝘪𝘲𝘶𝘦 𝘈𝘐 𝘱𝘭𝘢𝘵𝘧𝘰𝘳𝘮 𝘪𝘴 𝘢 𝘱𝘰𝘸𝘦𝘳𝘧𝘶𝘭 𝘤𝘢𝘵𝘢𝘭𝘺𝘴𝘵 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘮𝘰𝘥𝘦𝘳𝘯 𝘓𝘪𝘧𝘦 𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘴 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯, 𝘳𝘦𝘴𝘩𝘢𝘱𝘪𝘯𝘨 𝘩𝘰𝘸 𝘥𝘢𝘵𝘢 𝘪𝘴 𝘧𝘰𝘶𝘯𝘥, 𝘢𝘯𝘢𝘭𝘺𝘻𝘦𝘥 𝘢𝘯𝘥 𝘢𝘱𝘱𝘭𝘪𝘦𝘥 𝘪𝘯 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯-𝘮𝘢𝘬𝘪𝘯𝘨 𝘱𝘳𝘰𝘤𝘦𝘴𝘴𝘦𝘴 𝘪𝘯 𝘥𝘳𝘶𝘨 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳𝘺 𝘢𝘯𝘥 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵. 𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝒐𝒖𝒓 𝒘𝒆𝒃𝒔𝒊𝒕𝒆: https://bit.ly/3xEKWRT #drugdiscovery #leadership #innovation #genomics #toxicology #structuralbiology #sponsor #licensing #drugdiscoveryconference #ddipeu #worldbievents #scienceresearch